Evidence map›Paper›PMID 38539519›Full record

ArticleCancers2024

Natural Killer Cell Dysfunction in Premenopausal

Shaun Haran, Kantaraja Chindera, May Sabry, Nafisa Wilkinson, Rupali Arora, Agnieszka Zubiak, Thomas E Bartlett, Iona Evans, Allison Jones, Daniel Reisel and 10 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 5 countries.

Shaun HaranDepartment of Women's Cancer, Elizabeth Garrett Anderson (EGA) Institute for Women's Health, University College London (UCL), 72 Huntley Street, London WC1E 6DD, UK.
Kantaraja ChinderaDepartment of Women's Cancer, Elizabeth Garrett Anderson (EGA) Institute for Women's Health, University College London (UCL), 72 Huntley Street, London WC1E 6DD, UK.
May SabryInstitute of Immunity & Transplantation, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.
Nafisa WilkinsonDepartment of Cellular Pathology, University College London Hospitals (UCLH) NHS Trust, London NW1 2BU, UK.
Rupali AroraDepartment of Cellular Pathology, University College London Hospitals (UCLH) NHS Trust, London NW1 2BU, UK.
Agnieszka ZubiakInstitute of Immunity & Transplantation, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.
Thomas E BartlettDepartment of Statistical Science, University College London, London WC1E 7HB, UK.
Iona EvansDepartment of Women's Cancer, Elizabeth Garrett Anderson (EGA) Institute for Women's Health, University College London (UCL), 72 Huntley Street, London WC1E 6DD, UK.ORCID 0000-0002-0225-3154
Allison JonesDepartment of Women's Cancer, Elizabeth Garrett Anderson (EGA) Institute for Women's Health, University College London (UCL), 72 Huntley Street, London WC1E 6DD, UK.
Daniel ReiselDepartment of Women's Cancer, Elizabeth Garrett Anderson (EGA) Institute for Women's Health, University College London (UCL), 72 Huntley Street, London WC1E 6DD, UK.
Chiara HerzogEuropean Translational Oncology Prevention and Screening (EUTOPS) Institute, University of Innsbruck, 6060 Hall in Tirol, Austria.
Twana AlkasaliasDepartment of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Karolinska University Hospital, 14186 Stockholm, Sweden.ORCID 0000-0003-4567-2364
Mark NewmanPrecision Analytical Inc., McMinnville, OR 97128, USA.
Jaeyeon KimDepartment of Biochemistry and Molecular Biology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, School of Medicine, Indiana University, Indianapolis, IN 46202, USA.ORCID 0000-0003-2811-8281
Angelique Flöter RådestadDepartment of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Karolinska University Hospital, 14186 Stockholm, Sweden.ORCID 0000-0002-1068-9732
Kristina Gemzell-DanielssonDepartment of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Karolinska University Hospital, 14186 Stockholm, Sweden.ORCID 0000-0001-6516-1444
Adam N RosenthalDepartment of Women's Cancer, Elizabeth Garrett Anderson (EGA) Institute for Women's Health, University College London (UCL), 72 Huntley Street, London WC1E 6DD, UK.
Louis DubeauDepartment of Pathology, Keck School of Medicine, USC Norris Comprehensive Cancer Centre, University of Southern California, Los Angeles, CA 90033, USA.
Mark W LowdellInstitute of Immunity & Transplantation, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.ORCID 0000-0002-2600-5024
Martin WidschwendterDepartment of Women's Cancer, Elizabeth Garrett Anderson (EGA) Institute for Women's Health, University College London (UCL), 72 Huntley Street, London WC1E 6DD, UK.ORCID 0000-0002-7778-8380
University College London · GBKarolinska University Hospital · SEUniversity College London Hospitals NHS Foundation Trust · GBThe Royal Free Hospital · GBIndiana University Health · USUniversität Innsbruck · ATUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTissue-specificity for fimbrial fallopian tube ovarian carcinogenesis remains largely unknown in

methodsPremenopausal

results

conclusionsPhase-specific differential NK cell activity in

Indexed as

BRCA1epithelial ovarian cancerimmune surveillancenatural killer cells

Identifiers

PMID38539519
PMCPMC10968968
OpenAlexW4392925698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.